Proteomics data repositories: Providing a safe haven for your data and acting as a springboard for further research  by Vizcaíno, Juan Antonio et al.
J O U R N A L O F P R O T E O M I C S 7 3 ( 2 0 1 0 ) 2 1 3 6 – 2 1 4 6
ava i l ab l e a t www.sc i enced i r ec t . com
www.e l sev i e r . com/ loca te / j p ro tReview
Proteomics data repositories: Providing a safe haven for your
data and acting as a springboard for further researchJuan Antonio Vizcaínoa,1, Joseph M. Fostera,1 , Lennart Martensb,c,⁎
aEMBL Outstation, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
bDepartment of Medical Protein Research, VIB, B-9000 Ghent, Belgium
cDepartment of Biochemistry, Ghent University, B-9000 Ghent, BelgiumA R T I C L E I N F OAbbreviations: CV, Controlled Vocabulary
MRM, Multiple Reaction Monitoring; NIH, N
Referencing; PSI, Proteomics Standards Initi
Experiment Analysis Management System; T
⁎ Corresponding author. Department of Medi
+32 9 264 93 58; fax: +32 9 264 94 84.
E-mail address: lennart.martens@UGent.b
1 These authors contributed equally to this
1874-3919 © 2010 Elsevier B.V.
doi:10.1016/j.jprot.2010.06.008
Open access under A B S T R A C TKeywords: Despite the fact that data deposition is not a generalised fact yet in the field of proteomics,
several mass spectrometry (MS) based proteomics repositories are publicly available for the
scientific community. The main existing resources are: the Global Proteome Machine
Database (GPMDB), PeptideAtlas, the PRoteomics IDEntifications database (PRIDE), Tranche,
and NCBI Peptidome. In this review the capabilities of each of these will be described, paying
special attention to four key properties: data types stored, applicable data submission
strategies, supported formats, and available data mining and visualization tools.
Additionally, the data contents from model organisms will be enumerated for each
resource. There are other valuable smaller and/ormore specialized repositories but they will
not be covered in this review. Finally, the concept behind the ProteomeXchange consortium,
a collaborative effort among the main resources in the field, will be introduced.
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Public availability of data has been of paramount importance in
the fast development of most of the life sciences, and has
become one of the foundations of modern biology. Indeed,
researchers can now freely access DNA sequence information
[1], microarray and gene expression data [2,3], and small
molecules and chemicals [4]. At the protein level, well-
annotated protein sequences can be accessed in UniProt [5],
protein structures in the Protein Data Bank (PDB) [6], protein
modifications in UniMod [7] and RESID [8], and protein interac-
tions in the various resources forming the IMEX consortium [9].
This public availability of data is particularly interesting for
model organisms, as they have beenmost vigorously researched
using various high-throughput ‘omics’ analytical methodologies
over the last twodecades. Indeed, a largeproportionof thewealth
of data thus obtained has become publicly available to the
research community via various resources, including the ones
mentioned above. While the field of MS proteomics is therefore
currently ahead of certain other “omics” approaches (e.g.
metabolomics and glycomics) in terms of public data availability,
it is still trailingotherwell-established “omics”disciplinessuchas
genomics and transcriptomics in this respect. Indeed, compared
to these more mature fields, relatively few MS proteomics data
are currently available in the public domain, despite the
increasing popularity of the approach. As a consequence,
mandatory full data disclosure in the field of MS proteomics
remains an important work in progress [10].
This unfortunate situation is all the more regrettable since
there is some biological information that is uniquely available
through MS proteomics data. For instance, transcriptomics
approaches cannot predict accurately changes in active,mature
protein levels inaquantitativeway. Indeed, several studieshave
shown that a simple deduction of protein concentrations from
mRNA transcript analyses is not appropriate [11–13].Another topic that can only be well studied using MS
proteomics approaches is the detection and quantification of
co- or post-translational protein modifications [14]. A last
point to consider here is the use of proteomics as a valuable
tool for clinicians to develop new diagnostic methods or to
identify biomarkers. While microarray-based approaches
have also been used for this purpose, their usefulness may
ultimately be more limited. The main reason is that
proteomics, unlike transcriptomics, also has access to
secreted, circulating proteins in different proximal body
fluids such as blood plasma, serum, or urine, which present
highly convenient targets for detection and quantification
[15,16].
Despite the absence of a universal directive to make
published MS proteomics data publicly available, several
suitable repositories have been established to address the
demand for storage and availability of proteomics data in the
public domain. In parallel to the intrinsic complexity of the
field, proteomics repositories are quite heterogeneous and
have different interests and focus. Clearly, this variation is one
of the many reasons why data sharing in proteomics remains
limited: the current situation is simply too confusing for
researchers in the field. Therefore, it is important to mention
here that no single proteomics data resource will be ideally
suited to all possible use cases and all potential users. As a
matter of fact, existing resources already display a remarkable
complementarity in that respect.
The main publicly available databases for proteomics data
are the Global Proteome Machine Database (GPMDB) [17],
PeptideAtlas [18], the PRoteomics IDEntifications database
(PRIDE) [19], Tranche (http://www.tranche.proteomecommons.
org), and the most recent addition to the list, NCBI Peptidome
[20]. Additionally, there are other very valuable proteomics
resources such as Human Proteinpedia [21], PepSeeker [22], the
Genome Annotating Pipeline (GAPP) [23], MAPU [24], OPD [25],
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Theywill not be discussed here however, since they either they
are either too specialized, or contain data of human origin only
and not from model organisms (e.g. Human Proteinpedia and
MAPU). Additionally, the capabilities of these other resources
have already been reviewed recently [27,28]. Other proteomics
resources that store spectral libraries will not be reviewed here
either. If the reader is interested in such resources, the same
reviews previously cited constitute a good starting point for
these specialized resources [27,28].
Sharing data is generally considered to be good scientific
practice, since it allows other researchers to access, validate
and reanalyze one's findings. Thus, it makes possible the
confirmation of original results, the identification of errors
and allows the results to be used in novel ways. Additionally,
global analyses (meta-analyses) of heterogeneous high volume
data from different origins and obtained using different
experimental approaches, allow the extraction of novel
insights, providing added value to the original data. Such
meta-analyses in proteomics have been performed on data
from the HUPO Plasma Proteome [29] and Brain Proteome
projects [30]. Furthermore, proteomics resources offer unique
additional analytical opportunities for computational biolo-
gists such as research on peptide fragmentation patterns or
the generation of mass spectral libraries [28].
While the current rate of data accumulation, based
primarily upon voluntary submissions by authors, is already
increasing, there is a clear indication in the latest trends of a
much faster growth rate. This increased deposition drive is
based upon incentives from journals and funding agencies
alike. Several journals in the field, for instance Proteomics and
Molecular and Cellular Proteomics (MCP), have been following a
trend towards mandating public deposition of MS data to
support the publication of related manuscripts. At the same
time, several funding agencies such as the NIH in the US, and
The Wellcome Trust in the UK, are also enforcing the public
availability of produced data as a key requirement, with the
public deposition of data envisaged as a way to maximize the
value of the funds provided.
In the age of systems biology and data integration, it is
furthermore essential to count on proteomics data as a crucial
part of the “whole picture” of life. The aim of this review is
therefore to provide an overview of the current situation
regarding proteomics data repositories and to serve as a solid
starting point for those who want to perform proteomics data
mining in model organisms, either in a domain-specific or in an
integrative way.
We will here review each of the major proteomics
resources independently, although the capabilities and data
contents of PRIDE will be explained with a higher level of
detail. Each resource will also be analyzed in terms of the
information they contain from different model organisms.2. Information stored in MS based proteomics
resources: data formats and content
A large variety of MS techniques are available to researchers in
the field, with different experimental approaches serving
different goals. As a result, some researchers will use MS toidentify as many proteins as possible in their sample of
interest, while others may be interested in the characterisa-
tion of just a very small subset of proteins. A rather recent
development in proteomics concerns the application of
targeted approaches, typically using Selected Reaction Mon-
itoring (SRM) [31]. Furthermore, with quantification of proteins
becoming increasingly important, yet more different experi-
mental designs are being developed in the field.
This plethora of experimental approaches is relevant for
data resources, since the experimental approach and the type
of data generated influence the data formats that are
available. In general terms, each proteomics experiment
requires threemain types of information to be stored. Because
of the different nature of these, it is essential that all three are
kept. The three data types are:
i) Original experimental data recorded by the mass spectrometer
(primary data). The mass spectra recorded from the
instrument are typically stored originally in a binary
vendor or instrument specific formatted file, and data
can be very hard to access for users with different
experimental platforms [32]. These files can be converted
to open, XML-based file formats such as mzXML [33],
mzData or the newmzML format [34], that contain not only
the mass spectra per se but also some experimental
metadata. However, since these XML files can be very
large and therefore difficult to handle, the most common
practise remains the generation of text files containing
peak lists, derived from the original instrument files [35].
ii) Results inferred from the original primary data. Peptide and
protein sequences from sequence databases are usually
inferred from the acquired mass spectra using search
engines, although alternative approaches like de-novo
sequencing and searches based on spectral libraries are
becoming increasingly popular as well. Regardless of the
approach however, if peptides are identified, the non-
trivial job of mapping them to proteins must follow. The
inherent complexity of this protein inference step is often
not taken into account. Problems arise when the detected
peptide sequence potentially matches several proteins. If
this is the case, and it regularly is for shotgun proteomics
approaches, the decision about which of the several
potential proteins present in the sample is complex and
controversial [36]. For this reason, the protein inference
problem remains one of the bottlenecks for proteomics
data analysis and storage alike.
Depending on the search engine used to obtain the data,
these results can take a variety of formats, many of them
are text based. However, a higher level of complexity has
been introduced since experiments are increasingly being
focused in the quantification of the observed proteins. The
variety of methods and experimental approaches [37,38],
and the fact that many of them are not mature enough,
makes this kind of data very hard to be captured by the
proteomics repositories.Whereas the capture of qualitative
data by proteomics repositories can at present be prob-
lematic but is “under control”, the standardized incorpo-
ration of quantitative data remains very much a work in
progress.
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author contact, sample, experimental protocol, data
processing, and any other relevant piece of knowledge
that gives a proper and adequate technical and biological
background to the two first types of data.
Ideally, this information should be conveyed using
terms from a controlled vocabulary (CV) or ontology.
This way, the metadata is not only available to humans,
but it is also readily computer readable and can
therefore be queried easily and automatically. The
alternative, using simply free text, may be readable
and interpretable by humans but is impossible to query
in a structured and reliable way by computers.3. Proteomics data repositories and databases
The main characteristics of the existing proteomics resources
are summarized in Table 1. For each of the listed resources we
will divide the information into four categories: General
information, data submission and format support, data mining
and visualization, and data content for model organisms.
3.1. PRoteomics IDEntifications database (PRIDE)
3.1.1. General information
The PRIDE database (http://www.ebi.ac.uk/pride) at the Euro-
pean Bioinformatics Institute (EBI, Cambridge, UK) was
established as a public data repository to support the
publication of MS related studies. Thus, PRIDE stores three
different kinds of information: peptide and protein identifica-
tions derived from MS or MS/MS experiments, MS and MS/MS
mass spectra as peak lists, and all associated metadata [39].
Data in PRIDE is not reprocessed or altered in any way after
submission, since PRIDE represents the submitter's view of the
data. PRIDE allows data to remain private while anonymously
sharing it with journal editors and reviewers and it is now a
recommended submission point for several journals such as
Nature Biotechnology [40],NatureMethods [41], MCP and Proteomics.
PRIDE relies on twoadditional core tools: theOntology Lookup
Service (OLS) [42] and the Protein Identifier Cross-Referencing
(PICR) service [43]. PRIDE usesOLS to store, structure, and present
any and all metadata annotations. The widespread and persis-Table 1 –Main characteristics of the major proteomics reposito
PRIDE GPMD
Reprocessing of the data No Yes (X!Tan
and others
Editorial control No Yes
Level of annotation Detailed Very basic
Proteotypic peptides No Yes
Support for targeted approaches No Yes
Data submission PRIDE Converter
and FTP upload
Web interf
Submission of raw (binary) data No No
Access to deposited data Web interface, BioMart,




of filestent use of CVs and ontologies, along with the possibility to
perform queries based on these annotations, present a unique
feature of PRIDE when compared with any other proteomics
repository. This ready availability of rich metadata in the PRIDE
database has been crucial in supporting the globalmeta-analysis
of large, collaborative proteomics projects [29].
The PICR tool is used to keep up-to-datemappings of all the
submitted protein identifications in PRIDE to all known
accession numbers (including older accession numbers that
are no longer in use) for those proteins across the most
important protein databases. This way, protein identifications
submitted to PRIDE that were originally derived from different
databases, or from different time points of the same database,
become fully comparable.
3.1.2. Data submission and format support
Submissions to PRIDE are performed using a publicly available
XML data format called PRIDE XML. The development of the
PRIDEConverter submissiontool [44] (http://www.pride-converter.
googlecode.com)hasbeenkey in the largegrowthofdatacontent
in PRIDE during the last year [39]. PRIDE Converter has made
submission to PRIDE a simple and efficient process since a
submitter can now convert a wide variety of the most common
proteomics data formats directly to PRIDE XML in eight easy
steps in a user-friendly, wizard-like graphical user interface
(GUI), making the submission process much easier and more
straightforward. Examples of supported formats includeMascot
.dat and .mgf files [45], SEQUEST result (.out) and .dta files [46], X!
Tandem .xml files [47], OMSSA .omx files [48], SpectrumMill
result (.spo) and .pkl files, ProteinProphet/PeptideProphet
prot.xml and pep.xml files [49], mzXML [33], MS2 [50] and
mzData. At the moment PRIDE Converter handles spectrum
fragmentation annotation for certain formats: Mascot .dat
files, OMSSA .omx files and files from the open source LIMS
system ms_lims [51]. Once the files are converted, they are
automatically validated, making it possible simply to upload
the resulting PRIDE XML files to an EBI FTP server [52].
Very importantly, PRIDE has always committed to using
community data standards as formulated by the HUPO
Proteomics Standards Initiative (PSI, http://www.psidev.info).
The current PRIDE XML is therefore based on the mzData
format developed by HUPO PSI [53]. In the near future, PRIDE
will adopt the new formats mzML (for MS) [34] through the
jmzML API [54], and mzIdentML (for peptide and proteinries and databases.
B PeptideAtlas Tranche Peptidome
dem
)
Yes (TPP) No No
Yes No No
Basic Very basic Detailed
Yes No No
Yes No No












Fig. 1 – (A) A pie chart representing the protein identification
contributions of model organisms in PRIDE. * The asterisk
represents 12 species: G. gallus, Zea mays, Synechocystis sp.,
C. elegans, E. coli, Xenopus laevis, Emiliania huxleyi, Macaca
mulatta, N. tabacum, Ustilago maydis, Ashbya gossypii and
Neurospora crassa. (B) A pie chart representing the peptide
contributions of model organisms in PRIDE. * The asterisk
represents 7 species: Synechocystis sp., G. gallus, E. coli,
C. elegans, M. mulatta, E. huxleyi and N. tabacum.
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PRIDE is only supported to a limited extent [55]. The first
datasets containing actual protein expression values coming
from TMT/iTRAQ based approaches have been submitted, but
are not yet publicly available at the time of writing.
3.1.3. Data mining and visualization
Detailed, step-by-step usage of the PRIDE web interface has
been described extensively before [52,56,57]. All data
contained in PRIDE from a single species can be obtained via
the PRIDE ‘Browse’ page by clicking the relevant NEWT
taxonomy term.
Additionally, the PRIDE BioMart interface offers easy access
to species data. BioMart usage does not require any program-
ming skills and presents a query-oriented data management
system that allows for very powerful data retrieval [58]. A link to
the PRIDE BioMart is provided in the PRIDE main web page.
Alternatively, PRIDE can be also queried at the current BioMart
Central Portal [59] (http://www.biomart.org/biomart/martview/),
where it is also used to integrate information from PRIDE with
other very popular resources such as Ensembl [60], UniProt [5],
Reactome [61], InterPro [62], the Macromolecular Structure
Database (MSD) [63], or the IPI database [64] among a growing
list of others. At themoment, it is only possible to integrate two
resources at the same time but it is expected that this limitation
will disappear later this year when the new version of BioMart is
released.
For more sophisticated data mining purposes, users can
also download the corresponding XML files for each public
experiment from the EBI FTP server (ftp://ftp.ebi.ac.uk/pub/
databases/pride).
At present, PRIDE relies on the submitters in terms of the
quality of the existing datasets, as detailed proteomics data
cannotbecurated fromexisting literature.However, this situation
has started to change since a key ongoing development is the
creation of a new database called PRIDE-Q (for ‘Q-rated’) that will
contain only the highest-quality data from the PRIDE repository
[39].
3.1.4. Data content for model organisms
PRIDE contains a diverse range of organisms from all kingdoms
reflecting the varied interests and applications of proteomics for
studying fundamental biological phenomena. However, it is the
model organisms that are most useful in probing the complex-
ities of common across-species traits. At the start of February
2010, PRIDE contained about 2.9 million protein identifications
and 13.3 million peptide identifications, with an average of 5.6
spectra per peptide identification. Twenty-onemodel organisms
are represented, ranging from Synechocystis species (a cyanobac-
teria used in photosynthetic research) to D. rerio (zebra fish), a
common model for development and toxicology studies. Based
onthenumberofprotein identifications,Homosapiens is themost
represented species in PRIDE,withover twice asmany identifica-
tions as the next most common set of model organisms:
Drosophila melanogaster, mouse and Arabidopsis thaliana (Fig. 1A).
The peptide level shows similar statistics, with H. sapiens
having more than twice the peptide identifications assigned
than the next nearestmodel organismD. melanogaster (Fig. 1B).
It is interesting to note that when kingdoms are compared,
there is large bias towards animals, with plants coming adistant second in both peptide and protein identifications.
Data about the number of data depositions (groups of
experiments submitted at different time points, Fig. 2) show
that, as expected, H. sapiens comes with the largest number of
distinct data depositions. Animal model organisms such as
zebra fish, mouse and rat are all well represented (26, 24 and
15 data depositions respectively). Figures for plants (Arabidop-
sis and maize) are a bit lower (14 and 11 data depositions,
respectively), and the numbers of distinct data submissions
for some key model organisms such as Caenorhabditis elegans
and D. melanogaster remain only sporadic.
From PRIDE, a researcher can get the original author's view
on the data (peptide and protein identifications, and mass
spectra as peak lists) coming from awide variety of organisms,
since data are not reprocessed in any way. Thanks to the
extensive use of controlled vocabularies to report metadata, it
is possible to query PRIDE using a large variety of criteria, and
the proteomics information can be linked to other types of
biological data through various highly popular external
Fig. 2 – Model organism representation by number of data
depositions in PRIDE. * The asterisk represents 8 species:
X. laevis, U. maydis, O. sativa, N. tabacum, N. crassa,
M. mulatta, E. huxlei and A. gossypii.
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the BioMart. An up to date view on the protein identifications
reported is always available thanks to the continuous use of
the PICR service. Targeted approaches are not supported at the
moment and no information is provided about proteotypic
peptides.
3.2. The Global Proteome Machine database (GPMDB)
3.2.1. General information
The Global Proteome Machine database (http://www.thegpm.
org/) [17] was developed by Beavis informatics. MS/MS data is
(re-)processed mainly using the popular open source search
engine X!Tandem [47], although other related tools are now
available as well. Peptide and protein identifications are
generated and stored in the GPMDB. One of the ways to access
the data is through the boutique proteomes, which are a
collection of species-specific databases. Users can then
restrict the peptide identification analysis to a specific species
by choosing to search a particular proteome.
3.2.2. Data submission and format support
MS/MS data in different formats (.dta, .pkl, .mgf, mzXML, and
mzData) can be submitted to the GPM via the “simple search
page.” For files that are too big, a compressed format called
Common 1.0 (.cmn) can be used. Converter tools from peak list
formats to compressed .cmn files are also provided. Once the
data has been processed via X!Tandem, users can choose
whether or not to submit their data to GPMDB. Private data
submissions are also allowed. GPMDB data is stored in XML
files, which are indexed in a MySQL database.In addition to X!Tandem, users can also choose to use a
different search engine called X!Hunter to (re-)process their
data [65]. X!Hunter compares the experimentally observed
spectra with consensus mass spectra obtained from the
GPMDB. At present, support is available for human, mouse,
A. thaliana and Saccharomyces cerevisiae.
In order to improve comparability of data, GPMDB has also
implemented automatic conversion of identifiers for different
databases such as Ensembl, IPI, HGNC [66], NCBI genes and
UniProt accession numbers. Experimental metadata present
in GPMDB is essentially limited to the species information,
sometimes including additional information about the tissue/
organ and/or the subcellular location.
3.2.3. Data mining and visualization
The GPMDB web interface can be searched based on keywords
from protein or dataset descriptions. Another possible way to
access the data is the “ontology” option, where data from
human, mouse and yeast can be retrieved based on Gene
Ontology (GO) terms associated with identified proteins. The
visual representations available in the GPMDBweb interface are
quite diverse and powerful. There are three possible ways to
view identified proteins: gene view (G), protein and observed
peptide sequence view (P) and the X!Tandem view (X). It is also
possible to see annotated spectra.
When searches have been done against the Ensembl
database the results can be viewed as a KEGG [67] pathway,
by sorting proteins into metabolic pathway categories. Other
interesting developments include the web interface called
“pSYT,” which allows users to access information on phos-
phorylation of proteins present in GPMDB, and also the SNAP
web interface, which allows the visualization of peptides with
mutations when mapped to Ensembl.
One important feature of GPMDB is the support for proteo-
typic peptides. Proteotypic peptides for GPMDB are defined as
those that are more likely to be confidently observed, so in fact,
those which are most often detected. These peptides need not
be unique for a given protein. It is then possible to access all
proteotypic peptides from human and yeast origin. This
comprehensive list can be used by a search algorithm called X!
Tandem P3, which will only use this list of frequently detected
peptides to identify spectra in an attempt to improve the
confidence of the results. If this algorithm is used, data can also
be stored in GPMDB if desired by the submitter.
For advanced users, MS/MS files searched using the GPM
pipeline are available for download at ftp://ftp.thegpm.org/
data/msms. In addition, for some human proteins GPMDB
nowprovides transition prediction functionality, which can be
useful in the design of targeted approaches. The GPM-MRM
tool is integrated in the GPM web-interface (http://www.wiki.
thegpm.org/wiki/GPM-MRM).
GPMDB has not yet implemented a formal procedure to
perform quality control (QC) of the existing data. However,
peptide identifications are obtained through extensively used
software such as X!Tandem and X!Hunter, where fixed thresh-
olds are used inorder to assess that the resulting data is reliable.
3.2.4. Data content for model organisms
According to GPMDB official statistics (on February 2010),
56 million of the peptide observations are from human origin
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132.3 million). However, model organisms are very well repre-
sented: mouse (15 million, 11%), S. cerevisiae (6.8 million, 5%),
zebra fish (2.7 million, 2%), chicken and C. elegans (both around
2.5 million, 1.9%), Drosophila (2.0 million, 1.5%), Arabidopsis and
rat (both around 1.3 million, 1%), and finally dog, Xenopus and
rice (all of themcontaining around100,000 peptide observations
or less). There is more data from other model organisms in
GPMDB that can be accessed through the web interface search
functionality, but statistics are not available.
In addition, in the boutique proteomes it is possible to run the
searches versus a number of genomes from different prokaryote
model organisms such as Escherichia coli, Bacillus subtilis, Caulo-
bacter crescentus, Mycoplasma genitalium, Pseudomonas fluorescens,
the cyanobacterium Synechocystis, and Vibrio fischeri.
To summarize, researchers can get from GPMDB submitted
data reprocessed through the X!Tandem and/or X!Hunter
search engines: peptide and protein identifications and mass
spectra. It is possible to query the data based on species
information and, in certain cases also on subcellular location.
Information is available about proteotypic peptides and
targeted approaches are supported for human proteins.
3.3. PeptideAtlas
3.3.1. General information
The PeptideAtlas project, at the Institute of Systems Biology
(ISB, Seattle, USA) (http://www.peptideatlas.org/), annotates
genome sequences of different organisms with peptides and
proteins derived mainly from MS/MS data [18]. It is very
important to highlight here that prior to storage, as it happens
for GPMDB, all data in PeptideAtlas is reprocessed, in this case
via the popular Trans Proteomics Pipeline (TPP) [68].
All the processed results are loaded into SBEAMS (Systems
Biology ExperimentAnalysisManagement System)-Proteomics, a
proteomics analysis database built as a module under the
SBEAMS framework. The identified sequences are then mapped
onto their respective genome sequence, resulting into species or
sample-specific ‘builds’,which representall peptidesmapped toa
single reference Ensembl genome. As a matter of fact, PeptideA-
tlas is a peptide centric repository and aims to reprocess
periodically the available data with new tools for identification
and statistical validation, therefore providing an up to date vision
of a particular proteome.
3.3.2. Data submission and format support
Only MS/MS spectra are accepted, in either native raw, mzML
or mzXML format. Detailed instructions for potential sub-
mitters are available in http://www.peptideatlas.org/upload/.
To submit data the first step is to use the PeptideAtlas
feedback form. FTP upload support is also available. Similarly
to the other repositories, data can be kept private andwill only
become available when the submitter specifies it. PeptideAtlas
also performs automatic conversion of identifiers for different
databases such as Ensembl, IPI, RefSeq, Unigene and UniProt
accession numbers. For each peptide, external links to other
resources such as GPMDB or the Human Protein Atlas [69] are
provided.
PeptideAtlas contains in some cases basic metadata per
sample: e.g. the cell type, pathology-related information, orthe experimental technique used. However, if it exists, this
information is quite limited in most cases.
3.3.3. Data mining and visualization
All protein identifications can be viewed via the Ensembl
browser as Distributed Annotation System (DAS) tracks [70].
Unprocessed datasets (raw files), MS/MS files inmzXML format,
output files from search engines and lists of identifications can
be accessed at http://www.peptideatlas.org/repository.
One important feature of PeptideAtlas is the possibility of
accessing proteotypic peptides. In this case, the proteotypic
concept is more restricted than in GPMDB, since they are
defined as peptides that can uniquely and unambiguously
identify a specific protein. For each peptide in PeptideAtlas an
empirical proteotypicity score is calculated. Peptideswith high
scores are then most likely to be better targets for SRM
approaches. PeptideAtlas is defined as a resource for target
selection for emerging targeted proteomicsworkflows [18] and
currently supports targeted approaches in three ways:
- MRMAtlas (http://www.mrmatlas.com) is a compendiumof
targeted proteomics assays to detect and quantify yeast
proteins in complex proteome digests by mass spectrom-
etry [71]. It currently contains assays for nearly 1500 S.
cerevisiae proteins (21% of the yeast proteome).
- TIQAM (Targeted Identification for Quantitative Analysis
by MRM) [72], a desktop Java application to facilitate the
selection of peptide and transitions. It consists of three
applications: TIQAM-Digestor, TIQAM-PeptideAtlas and
TIQAM-Viewer.
- MaRiMba [73], a new component of the TPP since July 2009.
It makes use of spectral libraries to create transition lists.
Libraries of consensus spectra can be retrieved directly
from PeptideAtlas, or can be created using SpectraST [74],
the spectral library building and searching tool from TPP.
In terms of data visualization, one of the nicest features of
PeptideAtlas is theCytoscape [75] plug-in,which allows theuser
to viewthedistinct peptides for aparticularproteinasanetwork
withassociatedproteins. Finally, it is important tohighlight that
peptide and protein identifications are obtained through the
popular TPP, and the resulting data are then expected to be
trustworthy. However, equivalent to GPMDB, PeptideAtlas has
not implemented a formal QC of the existing data yet.
3.3.4. Data content for model organisms
As mentioned before PeptideAtlas builds are performed for
individual organisms and important sample groups (e.g.
plasma). By February 2010, there is a total of 11 builds available
and five of them come from model organisms: C. elegans (last
built on May 2008), Drosophila (July 2009), mouse plasma
(December 2009, but by February 2010 it was not available for
download yet), yeast (April 2009) and yeast MRM (also known
as MRMAtlas as cited before, built on February 2008).
To summarize, researchers can get from PeptideAtlas a
normalised view of the submitted data, reprocessed through
the popular TPP pipeline: peptide and protein identifications
and mass spectra. Within each build it is possible to link the
information between every peptide and the corresponding
gene in the Ensembl release. Information is available about
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Tranche at theUniversity ofMichigan (https://proteomecommons.
org/tranche/) is a distributed storage platform that supports
sharing and dissemination of potentially very large files and
proteomics related datasets. Tranche is based on an encrypted
peer-to-peer systemanddatauploaded intoTranche is split into
discrete units and split acrossmultiple servers [28]. Tranche is a
pure repository that hosts any kind of data and the concept of
the system is analogous to a computer hard disk. Therefore, it is
indeed the most universally applicable system. For this reason,
Tranche is starting to store other kinds of data different to
proteomics such as data sets from the personal genome project
(https://proteomecommons.org/news.jsp?i=664).
3.4.2. Data submission and format support
In order to submit data (in any format), it is necessary to request
anaccount first. It is also possible to keepdata private in thepre-
publication stage andmake it accessible for potential reviewers.
Access to uploading or downloadingdata is given via a JavaWeb
Start application. Once the application is loaded, users can
browse data by project or using the hash codes assigned by
Tranche to each dataset.
3.4.3. Data mining and visualization
The interface is quite simple and complex queries cannot
currently be performed since the annotation level is limited,
something that can constitute a problem if someone wants to
reuse the original data [76]. However, other repositories such
as PRIDE and PeptideAtlas have begun to interface with
Tranche as the mechanism to store and disseminate large
files (e.g. binary files from the mass spectrometers and output
files from search engines).
Thus, Tranche is an invaluable system to support the
exchange of large proteomics related files, which at present
cannot be stored anywhere else. These large files are meant
either for power users or for other resources such as
PeptideAtlas, to allow the reanalysis or reprocessing of large
volumes of data. However, due to the nature of data present in
Tranche, where virtually all kinds of files can be submitted
and annotation can be minimal, no formal QC is performed.
3.4.4. Data content for model organisms
At present, it is impossible to estimate accurately the amount
of data from different species that Tranche contains, since, as
mentioned before, the ‘Search Data’web functionality is quite
limited. More importantly, Tranche does not mandate the
provision of experimental metadata when a dataset is
submitted, so this information is simply not available for
many datasets. As a matter of fact, by February 2010 Tranche
contains 7101 data sets. Just as an example, if we look for
certain keywords related with species names we get the
following results: 305 datasets for human, 290 for rat, 78 for
mouse, 51 for S. cerevisiae and 14 for E. coli. However, some of
the retrieved results are not actual experimental datasets and,on the other hand, different figures are obtained depending on
the exact term the search is based on.
FromTranche researchers can usually get the corresponding
original raw data of a submitted proteomics experiment. Other
kind of files could be available as well, depending on each
submission, such as output files from the search engines used,




NCBI Peptidome (http://www.ncbi.nlm.nih.gov/peptidome) is the
most recent of the main proteomics repositories launched [77]
and for that reason is the one that contains the least amount of
data at present. It is essentially a sibling repository to PRIDE, since
data is not reprocessed in any way and the original view on the
data by the submitter is represented. Peptidome stores lists of
identified peptides and proteins, mass spectra as the supporting
evidence for these identifications, and descriptive information
about the biological samples, instrumentation and/or the infor-
matics pipeline. As with all the previous resources, reviewer
accounts can be created to access anonymously data in the
prepublication stage.
There are two types of components in Peptidome: Samples
(containing all the data related to the biological material, which
is derived from one or more MS runs) and Studies (collection of
samples from the same experiment).
3.5.2. Data submission and format support
Very detailed submission guidelines are available at http://
www.ncbi.nlm.nih.gov/peptidome/guidelines/#meta. Cur-
rently, there are four types of files required for a complete
submission [20]: metadata file that describes the overall
experiment, raw data files containing the MS and MS/MS
data (formats accepted:mzData,mzXML,mzML, and peak lists
such as .mgf, .pkl, .sqt or .dta files), output files from a peptide
identification program (mascot .dat files, OMSSA .omx and
pep.xml files are supported at the moment), and results
summary tables that describe the submitter's view of the final
processed results. Once all files are ready for submission, they
can be transferred to the NCBI via FTP.
NCBI Peptidome also supports quantitative data to a
certain extent [20]. Therefore, in the submission process it is
possible to include a single quantification value per protein,
peptide and/or spectrum. Also, metadata should be included
to describe the units (if applicable) and the methodology.
Metadata available in Peptidome per average submission is
quite rich. Therefore, detailed descriptions about the sample
or the experimental protocol can be found per sample.
However, it is unfortunate that at present, it is not possible
to query the data based on most of the criteria stored.
3.5.3. Data mining and visualization
The Peptidome web interface is the primary way to access the
data. However, it is also possible to access thedata inPeptidome
in an indirect way via the NCBI's Entrez search and linking
system [78].
In addition, all original data files (spectra files, identification
results and supplementary data) are available for download at
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mal QC of the data in Peptidomehas not been implemented yet.
3.5.4. Data content for model organisms
As stated before, due to Peptidome's recent launch it currently
contains the least amount of data. By February 2010 it contained
23 public studies, ten of them from human origin. In terms of
number of studies coming from model organisms, the
most represented organism in Peptidome so far is S. cerevisiae
(7 studies). Apart from that, there is data (one study each) from
mouse, E. coli and Ciona intestinalis, the sea squirt, amajormodel
for developmental biologists.
To summarize, researchers can get fromNCBI Peptidome the
original author's view on the data, since as it happens for PRIDE,
data is not reprocessed in any way: peptide and protein
identifications, and mass spectra as peak lists. Rich metadata
is present but unfortunately, complex queries cannot be made
at present. Information about proteotypic peptides is not
available and targeted approaches are not currently supported.4. Future perspectives and conclusions
The main proteomics repositories (PRIDE, NCBI Peptidome,
Tranche, PeptideAtlas andGPMDB) are currentlyworking on the
implementation of a system called ProteomeXchange that will
allow proteomics data sharing between all the members in a
scheduled and well-structured way [79]. The capabilities of the
different resources are complementary so the idea behind
ProteomeXchange is to have a single point of submission for
data deposition, while providing multiple points of access for
data visualization and analysis.
PRIDE and NCBI Peptidome are envisioned as the initial
submission points, Tranche is the storage place for large files
and acts as the primary data transport hub, and PeptideAtlas and
GPMDB will be notified immediately when datasets are made
public in order to get full advantage of metadata present in the
other resources before reprocessing all the data. Draft guidelines
for submissions are available (see http://www.proteomexchange.
org) and a large-scale ProteomeXchange pilot submission has
alreadybeenperformed [39]. In the samecontext, PRIDE andNCBI
Peptidome, the most similar repositories, formally agreed that
they will replicate and share all their public data, again ensuring
that data becomes optimally visible to the scientific community.
However, the actual exchange has not started yet at the time of
writing.
All together, these initiatives are expected to help overcome
the community's reticence about data disclosure in the field.
However, it must also be taken into account that this data-
sharing process is very resource-intensive and time-consuming
for the data repositories.
It seems clear to us that more proteomics data from model
organisms is needed in public repositories since the figures
remain of a different order ofmagnitude compared to data from
human origin. Communities devoted to particular organisms
would be the first to reap benefit from increased data sharing,
since it is clear that the higher the diversity of data going into
proteomics repositories (in terms of sample, experimental
technique, instrument or search engine), the higher the number
of unique peptides sequences that are found [39].Since the current volume of proteomics data deposition is
rapidly increasing, new approaches based on the reanalysis of
the data and/or new uses of the stored data will also become
possible. Targeted approaches represent another promising
field and researchers can already make heavy use of the
proteomics resources in order to improve the experimental
designs in these types of experiments.Acknowledgments
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